Page last updated: 2024-09-03

antiprimod and Bone Loss, Osteoclastic

antiprimod has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Batchu, RB; Blotta, S; Catley, L; Chauhan, D; Hamasaki, M; Hideshima, T; Jacob, GS; Munshi, NC; Neri, P; Picker, D; Prabhala, R; Schipani, E; Shammas, M; Tassone, P; Venuta, S; Yasui, H	1

Other Studies

1 other study(ies) available for antiprimod and Bone Loss, Osteoclastic

Article	Year
Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma. Leukemia, 2007, Volume: 21, Issue:12 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Bone Resorption; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Metabolic Networks and Pathways; Mice; Mice, Nude; Mice, SCID; Multiple Myeloma; Neoplasm Proteins; Osteogenesis; Signal Transduction; Spiro Compounds; Xenograft Model Antitumor Assays	2007

Article

Year

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.

Leukemia, 2007, Volume: 21, Issue:12

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Bone Resorption; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Metabolic Networks and Pathways; Mice; Mice, Nude; Mice, SCID; Multiple Myeloma; Neoplasm Proteins; Osteogenesis; Signal Transduction; Spiro Compounds; Xenograft Model Antitumor Assays

2007